CNO Financial Reports Strong Q4 & Full-Year 2025 Results, Exceeding Guidance with 11% Operating EPS Growth
CNO sits 22% above its 52-week low of $34.63.
Summary
CNO Financial Group announced strong Q4 and full-year 2025 financial results, exceeding all guidance metrics with significant operating EPS growth, record sales, and robust capital returns.
Key Events · Earnings and Guidance · CNO
-
Exceeded 2025 Guidance
The company achieved, and in most cases exceeded, all its 2025 guidance metrics, demonstrating strong operational execution.
-
Operating EPS Growth
Full-year 2025 net operating income per diluted share grew 11% to $4.40, with Q4 2025 operating EPS up 12% to $1.47.
-
Record Sales Momentum
Total new annualized premiums (NAP) grew 15% for the full year, setting a new company record and marking the 14th consecutive quarter of strong insurance sales.
-
Significant Shareholder Returns
The company repurchased $60 million of common stock in Q4 and $320 million for the full year, an 11% increase from 2024, reflecting healthy free cash flow generation.
Analysis · CNO · Finance
CNO Financial Group delivered a robust fourth quarter and full-year 2025 performance, surpassing all its 2025 guidance metrics. The company demonstrated consistent growth across key operational and financial indicators, including an 11% increase in full-year operating earnings per share and a 15% rise in total new annualized premiums. Strong capital management was evident through substantial share repurchases and an improved debt-to-capital ratio. These positive results, coupled with the stock trading near its 52-week high, suggest strong investor confidence and operational execution.
At the time of this filing, CNO was trading at $42.31 on NYSE in the Finance sector, with a market capitalization of approximately $4B. The 52-week trading range was $34.63 to $44.19. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.